Clinical trial
A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age…
NCT00109564 · Targacept Inc., Industry · Completed
Key facts
| NCT number | NCT00109564 |
|---|---|
| Title | A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI) |
| Official title | A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI) |
| Lead sponsor | Targacept Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age-Related Memory Disorders |
| Intervention type | Drug |
| Interventions | ispronicline (nicotinic acetylcholine receptor agonist) |
| Enrollment | 174 |
| Start date | Jan 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Apr 29, 2005 |
| Last update posted | Jul 18, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: